The Vivid Vision Perimetry (VVP) visual field test couples software with a virtual reality headset. This prospective case-control study tested the feasibility of the VVP test in a pediatric population. Source: AAO
Two presentations at the ASRS 2024 Annual Meeting focused on the ways social determinants of health have an effect on retinal detachment and on overall eye care. Source: AAO
A systematic literature review was conducted to provide a detailed picture of some of the medications for which there is published evidence of orbital inflammatory disease–related adverse events. Source: AAO
Patients with a history of melatonin use could be nearly half as likely to develop AMD or show AMD progression as patients who did not take the supplement, a retrospective evaluation suggests. Source: AAO
According to this national database study, lower income, Medicare insurance status, and rural residency are among factors that may be barriers to care for certain patients with ocular malignancies. Source: AAO
For some patients with suspected small choroidal melanomas, it may be reasonable to monitor tumor growth for up to a year without having to worry about increased risk of metastatic death. Source: AAO
Nonanterior ischemic optic neuropathy (NAION) has been noted in patients taking semaglutide, low birth weight may not be linked with adult hypertensive retinopathy, and Case Western Reserve University receives a research grant to study an oral retinitis pigmentosa therapy. Source: AAO
Teaching fellows how to repair primary rhegmatogenous retinal detachment (RRD) requires significantly more time, but Medicare reimbursements appear to cover only a portion of the additional costs. Source: AAO
Favorable clinical trial results suggest that Corneal Tissue Addition Keratoplasty (CTAK) may be a promising alternative to artificial inlays for patients with corneal ectasia. Source: AAO
For patients with Fuchs dystrophy, a second-eye Descemet membrane endothelial keratoplasty (DMEK) surgery shortly after the first does not appear to negatively impact outcomes for either eye. Source: AAO
Tel: 518-580-0553
Get Directions »
Tel: 518-580-0553
Get Directions »
Tel: +1 (518) 580-0553
Get Directions »
